Annual CFI
$12.55 M
+$46.86 M+136.58%
December 31, 2023
Summary
- As of February 10, 2025, DCPH annual cash flow from investing activities is $12.55 million, with the most recent change of +$46.86 million (+136.58%) on December 31, 2023.
- During the last 3 years, DCPH annual CFI has fallen by -$15.91 million (-55.90%).
Performance
DCPH Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFI
$62.63 M
+$60.43 M+2748.16%
March 1, 2024
Summary
- As of February 10, 2025, DCPH quarterly cash flow from investing activities is $62.63 million, with the most recent change of +$60.43 million (+2748.16%) on March 1, 2024.
- Over the past year, DCPH quarterly CFI has increased by +$21.23 million (+51.27%).
Performance
DCPH Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
$110.59 M
+$98.05 M+781.30%
March 1, 2024
Summary
- As of February 10, 2025, DCPH TTM cash flow from investing activities is $110.59 million, with the most recent change of +$98.05 million (+781.30%) on March 1, 2024.
- Over the past year, DCPH TTM CFI has increased by +$83.94 million (+314.92%).
Performance
DCPH TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
DCPH Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +136.6% | +51.3% | +314.9% |
| 3 y3 years | -55.9% | +51.3% | +314.9% |
| 5 y5 years | +672.0% | +51.3% | +314.9% |
DCPH Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.9% | -373.4% | -36.7% | -266.4% | -37.5% | -217.0% |
| 5 y | 5-year | -92.9% | -3769.8% | -49.5% | -266.4% | -37.5% | -516.4% |
| alltime | all time | -92.9% | -3769.8% | -49.5% | -570.7% | -37.5% | -518.2% |
Deciphera Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $62.63 M(+2748.2%) | $110.59 M(+781.3%) |
| Dec 2023 | $12.55 M(-136.6%) | $2.20 M(-94.7%) | $12.55 M(-52.9%) |
| Sep 2023 | - | $41.40 M(+849.4%) | $26.65 M(-228.0%) |
| Jun 2023 | - | $4.36 M(-112.3%) | -$20.82 M(-83.9%) |
| Mar 2023 | - | -$35.41 M(-317.2%) | -$129.38 M(+277.1%) |
| Dec 2022 | -$34.31 M(-119.4%) | $16.30 M(-368.6%) | -$34.31 M(-171.0%) |
| Sep 2022 | - | -$6.07 M(-94.2%) | $48.34 M(-29.8%) |
| Jun 2022 | - | -$104.19 M(-274.7%) | $68.85 M(-38.8%) |
| Mar 2022 | - | $59.65 M(-39.7%) | $112.59 M(-36.3%) |
| Dec 2021 | $176.85 M(+521.4%) | $98.95 M(+585.2%) | $176.85 M(+42.6%) |
| Sep 2021 | - | $14.44 M(-123.9%) | $123.97 M(+11.3%) |
| Jun 2021 | - | -$60.45 M(-148.8%) | $111.36 M(-27.7%) |
| Mar 2021 | - | $123.91 M(+168.9%) | $154.06 M(+441.3%) |
| Dec 2020 | $28.46 M | $46.08 M(+2430.4%) | $28.46 M(-278.5%) |
| Sep 2020 | - | $1.82 M(-110.3%) | -$15.94 M(-94.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$17.75 M(+950.4%) | -$312.57 M(+10.6%) |
| Mar 2020 | - | -$1.69 M(-200.6%) | -$282.56 M(-38.6%) |
| Dec 2019 | -$460.52 M(>+9900.0%) | $1.68 M(-100.6%) | -$460.52 M(-0.4%) |
| Sep 2019 | - | -$294.81 M(-2505.4%) | -$462.50 M(+175.4%) |
| Jun 2019 | - | $12.26 M(-106.8%) | -$167.91 M(-7.6%) |
| Mar 2019 | - | -$179.65 M(>+9900.0%) | -$181.69 M(+8181.3%) |
| Dec 2018 | -$2.19 M(+440.4%) | -$303.00 K(+40.3%) | -$2.19 M(+8.6%) |
| Sep 2018 | - | -$216.00 K(-85.8%) | -$2.02 M(+0.7%) |
| Jun 2018 | - | -$1.52 M(+909.3%) | -$2.01 M(+283.7%) |
| Mar 2018 | - | -$151.00 K(+16.2%) | -$523.00 K(+28.8%) |
| Dec 2017 | -$406.00 K(+82.1%) | -$130.00 K(-35.6%) | -$406.00 K(+47.1%) |
| Sep 2017 | - | -$202.00 K(+405.0%) | -$276.00 K(+273.0%) |
| Jun 2017 | - | -$40.00 K(+17.6%) | -$74.00 K(+117.6%) |
| Mar 2017 | - | -$34.00 K | -$34.00 K |
| Dec 2016 | -$223.00 K(+57.0%) | - | - |
| Dec 2015 | -$142.00 K | - | - |
FAQ
- What is Deciphera Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals annual CFI year-on-year change?
- What is Deciphera Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals quarterly CFI year-on-year change?
- What is Deciphera Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Deciphera Pharmaceuticals?
- What is Deciphera Pharmaceuticals TTM CFI year-on-year change?
What is Deciphera Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of DCPH is $12.55 M
What is the all time high annual CFI for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high annual cash flow from investing activities is $176.85 M
What is Deciphera Pharmaceuticals annual CFI year-on-year change?
Over the past year, DCPH annual cash flow from investing activities has changed by +$46.86 M (+136.58%)
What is Deciphera Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of DCPH is $62.63 M
What is the all time high quarterly CFI for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high quarterly cash flow from investing activities is $123.91 M
What is Deciphera Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, DCPH quarterly cash flow from investing activities has changed by +$21.23 M (+51.27%)
What is Deciphera Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of DCPH is $110.59 M
What is the all time high TTM CFI for Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals all-time high TTM cash flow from investing activities is $176.85 M
What is Deciphera Pharmaceuticals TTM CFI year-on-year change?
Over the past year, DCPH TTM cash flow from investing activities has changed by +$83.94 M (+314.92%)